nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing the discovery of medications for autism spectrum disorder using new technologies to reveal social brain circuitry in rodents
|
Kas, Martien J. |
|
2014 |
231 |
6 |
p. 1147-1165 |
artikel |
2 |
A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
|
Jucaite, Aurelija |
|
2013 |
231 |
6 |
p. 1251-1265 |
artikel |
3 |
Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives
|
Kas, Martien J. |
|
2013 |
231 |
6 |
p. 1125-1146 |
artikel |
4 |
Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders
|
Politte, Laura C. |
|
2013 |
231 |
6 |
p. 1023-1036 |
artikel |
5 |
Autism spectrum disorders - an emerging area in psychopharmacology
|
Steckler, Thomas |
|
2014 |
231 |
6 |
p. 977-978 |
artikel |
6 |
Biomarkers in autism spectrum disorder: the old and the new
|
Ruggeri, Barbara |
|
2013 |
231 |
6 |
p. 1201-1216 |
artikel |
7 |
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development
|
Pop, Andreea S. |
|
2013 |
231 |
6 |
p. 1217-1226 |
artikel |
8 |
Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish
|
Aigner, Stefan |
|
2013 |
231 |
6 |
p. 1089-1104 |
artikel |
9 |
Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders
|
Khatri, Nidhi |
|
2013 |
231 |
6 |
p. 1191-1200 |
artikel |
10 |
Neurobiology of autism gene products: towards pathogenesis and drug targets
|
Kleijer, Kristel T. E. |
|
2014 |
231 |
6 |
p. 1037-1062 |
artikel |
11 |
Neuroimaging Endophenotypes in Animal Models of Autism Spectrum Disorders: Lost or Found in Translation?
|
Petrinovic, Marija M. |
|
2013 |
231 |
6 |
p. 1167-1189 |
artikel |
12 |
Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons
|
Dage, Jeffrey L. |
|
2014 |
231 |
6 |
p. 1105-1124 |
artikel |
13 |
Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care
|
Murray, Macey L. |
|
2013 |
231 |
6 |
p. 1011-1021 |
artikel |
14 |
Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study
|
Hsia, Yingfen |
|
2013 |
231 |
6 |
p. 999-1009 |
artikel |
15 |
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
|
Pop, Andreea S. |
|
2012 |
231 |
6 |
p. 1227-1235 |
artikel |
16 |
Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation
|
Devine, Darragh P. |
|
2013 |
231 |
6 |
p. 979-997 |
artikel |
17 |
The challenges of clinical trials in fragile X syndrome
|
Jacquemont, Sébastien |
|
2013 |
231 |
6 |
p. 1237-1250 |
artikel |
18 |
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders
|
Cocks, Graham |
|
2013 |
231 |
6 |
p. 1079-1088 |
artikel |
19 |
Using genetic findings in autism for the development of new pharmaceutical compounds
|
Vorstman, Jacob A. S. |
|
2013 |
231 |
6 |
p. 1063-1078 |
artikel |